razoxane has been researched along with Experimental Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gershanovich, ML | 1 |
| Giraldi, T; Sava, G | 1 |
| Alberts, DS; Dawson, BV; Dorr, RT; Hendrix, M; Shipp, NG | 1 |
| Hoshino, A; Inaba, M; Komatsu, T; Narita, T; Takase, M; Tsukagoshi, S; Yaguchi, S | 1 |
1 review(s) available for razoxane and Experimental Leukemia
| Article | Year |
|---|---|
Selective antimetastatic drugs (review).
Topics: Animals; Antineoplastic Agents; Hemostasis; Humans; Leukemia; Leukemia, Experimental; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Protease Inhibitors; Rats; Razoxane | 1981 |
3 other study(ies) available for razoxane and Experimental Leukemia
| Article | Year |
|---|---|
[Cardioxan: prevention of anthracycline-related cardiotoxicity].
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cardiotonic Agents; Cardiovascular Agents; Chelating Agents; Child; Clinical Trials as Topic; Doxorubicin; Echocardiography; Electrocardiography; Female; Heart; Heart Diseases; Humans; Immunosuppressive Agents; Leukemia, Experimental; Male; Mice; Mice, Inbred C57BL; Neoplasms; Neoplasms, Experimental; Razoxane; Time Factors | 2004 |
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Heart Diseases; Humans; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Microscopy, Electron; Mitoxantrone; Multiple Myeloma; Myocardium; Rats; Rats, Sprague-Dawley; Razoxane; Sensitivity and Specificity; Tumor Cells, Cultured | 1993 |
Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Leukemia P388; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Piperazines; Razoxane; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |